Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Gel Manufacturing: SOP for Handling Market Complaints Related to Gel Products – V 2.0

Posted on By

Gel Manufacturing: SOP for Handling Market Complaints Related to Gel Products – V 2.0

Standard Operating Procedure for Handling Market Complaints Related to Gel Products in Gel Manufacturing


Department Gel Manufacturing
SOP No. SOP/GM/117/2025
Supersedes SOP/GM/117/2022
Page No. Page 1 of 12
Issue Date 02/06/2025
Effective Date 04/06/2025
Review Date 02/06/2027

1. Purpose

To define the procedure for handling, investigating, and responding to market complaints related to gel-based pharmaceutical products.

2. Scope

This procedure applies to all market complaints received for gel formulations manufactured at the facility, whether received directly from customers,

healthcare professionals, or regulatory authorities.

3. Responsibilities

  • QA Department: Receives complaints, coordinates investigations, and ensures timely closure.
  • Production Head: Supports technical investigation and implements corrective actions if manufacturing-related.
  • QC Department: Performs analytical review or re-testing of retained samples.
  • Regulatory Affairs: Notifies regulatory agencies if required.
See also  Gel Manufacturing: SOP for Development of Oil-Based Gels - V 2.0

4. Accountability

Head – Quality Assurance

5. Procedure

5.1 Receipt of Complaint

  1. QA shall receive complaints through phone, email, written communication, or online reporting.
  2. Log complaint details in the Complaint Register within 24 hours of receipt.
  3. Assign a unique Complaint Reference Number (CRN).

5.2 Initial Assessment

  1. Determine if the complaint is quality-related, adverse event-related, or logistical.
  2. For quality complaints, proceed with a formal investigation.

5.3 Investigation

  1. Review batch manufacturing records, in-process control results, and final QC data.
  2. Retrieve and analyze retention samples where applicable.
  3. Involve cross-functional teams as necessary to trace root cause.

5.4 Categorization of Complaint

  • Critical: Product defect with safety risk (e.g., microbial contamination, mislabeling).
  • Major: Quality non-conformance affecting performance or stability.
  • Minor: Cosmetic or packaging defects with no product impact.
See also  Gel Manufacturing: SOP for Operation of Gel Mixing Vessels - V 2.0

5.5 Corrective and Preventive Action (CAPA)

  1. Define appropriate CAPA based on investigation findings.
  2. Record CAPA in the CAPA register and link it to the complaint file.
  3. Monitor effectiveness of CAPA over a defined timeline.

5.6 Closure and Response

  1. Compile investigation findings and CAPA summary.
  2. Communicate response to the complainant within 30 working days.
  3. Archive complaint file with related batch and CAPA documents.

5.7 Regulatory Reporting

  1. If complaint involves adverse event or reportable defect, inform regulatory bodies as per pharmacovigilance norms.

6. Abbreviations

  • QA: Quality Assurance
  • QC: Quality Control
  • CAPA: Corrective and Preventive Action
  • CRN: Complaint Reference Number

7. Documents

  1. Complaint Record Form – Annexure-1
  2. CAPA Log Sheet – Annexure-2
  3. Complaint Register – Annexure-3

8. References

  • WHO TRS 986 Annex 2: GMP Guidelines for Complaints and Product Recalls
  • 21 CFR 211.198: Complaint Files (USFDA)
See also  Gel Manufacturing: SOP for Calibration and Maintenance of pH Meter - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Jr. Production Chemist QA Executive Head – Manufacturing
Department Gel Manufacturing Quality Assurance Manufacturing

11. Annexures

Annexure-1: Complaint Record Form

Complaint Reference No.
Date Received
Complainant Details
Product Name
Batch No.
Nature of Complaint
Initial Assessment
Investigation Summary
CAPA Taken
Date of Response
Signature (QA)

Annexure-2: CAPA Log Sheet

CAPA No. Related Complaint Ref. No. Action Description Target Date Status Remarks

Annexure-3: Complaint Register Format

CRN Date Product Batch No. Complaint Type Status Closure Date

Revision History

Revision Date Revision No. Change Description Reason Approved By
21/09/2022 1.0 Initial issue New SOP QA Head
02/06/2025 2.0 Added regulatory reporting section, updated annexures Annual review QA Head
Gels V 2.0 Tags:gel excipients SOP, gel extrudability SOP, gel formulation process guidelines, gel formulation safety SOP, gel formulation SOP template, gel homogenization SOP, gel ingredient weighing SOP, gel labeling and documentation SOP, gel microbial contamination SOP, gel packaging SOP, gel viscosity measurement SOP, gel viscosity testing SOP, pharmaceutical gel SOP, quality control SOP gel formulations, SOP for carbopol gel formulation, SOP for gel pH adjustment, SOP for gel spreadability test, stability testing SOP gel, standard operating procedure gel preparation, topical gel manufacturing SOP

Post navigation

Previous Post: Sterile Injectable Manufacturing: SOP for Use of Personal Protective Equipment (PPE) in Dispensing Areas – V 2.0
Next Post: Audit Risks When SOPs Lack Clear Version Identification

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version